ZA902602B - Synergistic compositions containing ketanserin - Google Patents

Synergistic compositions containing ketanserin

Info

Publication number: ZA902602B
Authority: ZA; South Africa
Prior art keywords: ketanserin; compositions containing; synergistic compositions; synergistic; containing ketanserin
Prior art date: 1989-04-05

Application number

ZA902602A

Other languages

English (en)

Inventor

Giuseppe Assogna

Assogna Giuseppe

Giovanni Lucchetti

Lucchetti Giovanni

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-04-05

Filing date

1990-04-04

Publication date

1991-12-24

1990-04-04 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1991-12-24 Publication of ZA902602B publication Critical patent/ZA902602B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

ZA902602A 1989-04-05 1990-04-04 Synergistic compositions containing ketanserin ZA902602B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33347189A	1989-04-05	1989-04-05

Publications (1)

Publication Number	Publication Date
ZA902602B true ZA902602B (en)	1991-12-24

Family

ID=23302937

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA902602A ZA902602B (en)	1989-04-05	1990-04-04	Synergistic compositions containing ketanserin

Country Status (9)

Country	Link
EP (1)	EP0391462A1 (pt)
JP (1)	JPH02290823A (pt)
KR (1)	KR900017586A (pt)
AU (1)	AU5295790A (pt)
CA (1)	CA2013801A1 (pt)
IL (1)	IL93990A0 (pt)
NZ (1)	NZ233122A (pt)
PT (1)	PT93654A (pt)
ZA (1)	ZA902602B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5073539A (en) *	1990-01-22	1991-12-17	Ciba-Geigy Corporation	Transdermal administration of zwitterionic drugs
YU48602B (sh) *	1991-11-25	1998-12-23	Krka Tovarna Zdravil P.O.	Postupak za dobijanje stabilne formulacije soli enalaprila
AU3290397A (en) *	1996-06-10	1998-01-07	Depomed, Inc.	Gastric-retentive oral controlled drug delivery system with enhanced retention properties
SG150533A1 (en)	2003-11-20	2009-03-30	Janssen Pharmaceutica Nv	6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2- quinoxalinones as poly(adp-ribose) polymerase inhibitors
NZ546990A (en)	2003-11-20	2010-03-26	Janssen Pharmaceutica Nv	7-Phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
WO2006003148A1 (en)	2004-06-30	2006-01-12	Janssen Pharmaceutica N.V.	Quinazolinedione derivatives as parp inhibitors
AU2005259189B2 (en)	2004-06-30	2011-04-21	Janssen Pharmaceutica N.V.	Phthalazine derivatives as PARP inhibitors
CN1976906B (zh)	2004-06-30	2010-09-01	詹森药业有限公司	用作parp抑制剂的取代2-烷基喹唑啉酮衍生物
GB0624084D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amino acid salts
GB0624082D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril metal salts
GB0624090D0 (en) *	2006-12-01	2007-01-10	Selamine Ltd	Ramipril amine salts
JP5545955B2 (ja)	2007-03-08	2014-07-09	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体
US8404713B2 (en)	2007-10-26	2013-03-26	Janssen Pharmaceutica Nv	Quinolinone derivatives as PARP inhibitors
AU2009228945B2 (en)	2008-03-27	2013-05-02	Janssen Pharmaceutica Nv	Quinazolinone derivatives as tubulin polymerization inhibitors
JP5492183B2 (ja)	2008-03-27	2014-05-14	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｐａｒｐおよびチューブリン重合阻害剤としてのテトラヒドロフェナントリジノンおよびテトラヒドロシクロペンタキノリノン
SI23149A (sl) *	2009-09-21	2011-03-31	Silverstone Pharma	Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
CN109157507A (zh) *	2018-09-14	2019-01-08	上海禾丰制药有限公司	酒石酸酮色林注射液及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3633496A1 (de) *	1986-10-02	1988-04-14	Hoechst Ag	Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln

1990
- 1990-03-27 EP EP90200719A patent/EP0391462A1/en not_active Withdrawn
- 1990-03-28 NZ NZ233122A patent/NZ233122A/xx unknown
- 1990-04-03 KR KR1019900004563A patent/KR900017586A/ko not_active Withdrawn
- 1990-04-03 IL IL93990A patent/IL93990A0/xx unknown
- 1990-04-03 JP JP2087645A patent/JPH02290823A/ja active Pending
- 1990-04-04 ZA ZA902602A patent/ZA902602B/xx unknown
- 1990-04-04 PT PT93654A patent/PT93654A/pt not_active Application Discontinuation
- 1990-04-04 CA CA002013801A patent/CA2013801A1/en not_active Abandoned
- 1990-04-05 AU AU52957/90A patent/AU5295790A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU5295790A (en)	1990-10-11
IL93990A0 (en)	1991-01-31
EP0391462A1 (en)	1990-10-10
PT93654A (pt)	1990-11-20
JPH02290823A (ja)	1990-11-30
CA2013801A1 (en)	1990-10-05
KR900017586A (ko)	1990-12-19
NZ233122A (en)	1991-10-25

Publication	Publication Date	Title
IL98463A0 (en)	1992-07-15	Synergistic antimalarial composition containing benflumetol
IL98177A0 (en)	1992-06-21	Synergistic compositions containing tgf-beta
IL93990A0 (en)	1991-01-31	Synergistic compositions containing ketanserin
EP0336489A3 (en)	1990-05-16	Imazalil containing synergistic compositions
KR950013915B1 (en)	1995-11-18	Synergistic surfactant compositions
GB9012993D0 (en)	1990-08-01	Dental compositions
GB8904862D0 (en)	1989-04-12	Compositions
HU900135D0 (en)	1990-03-28	New harbicid compositions
ZA906084B (en)	1991-05-29	Biocidal compositions
SG27894G (en)	1995-03-17	Injectable compositions containing 25-cyclohexyl-avermectin B1
ZA908514B (en)	1991-08-28	Filme-forming compositions
GB8927010D0 (en)	1990-01-17	Compositions
GB8902894D0 (en)	1989-03-30	Compositions
GB9009573D0 (en)	1990-06-20	Compositions
GB8909731D0 (en)	1990-04-25	Compositions
GB8905512D0 (en)	1989-04-19	Filler compositions
IE901217L (en)	1990-10-05	Synergistic compositions containing ketanserin
GB8924295D0 (en)	1989-12-13	Oral compositions
IE892824L (en)	1990-03-02	Synergistic mixture
GB9006022D0 (en)	1990-05-09	Synergistic compositions
GB8918570D0 (en)	1989-09-27	Sterilising compositions
GB8918569D0 (en)	1989-09-27	Sterilising compositions
GB8920853D0 (en)	1989-11-01	Compositions
GB8906337D0 (en)	1989-05-04	Compositions
GB8918863D0 (en)	1989-09-27	Compositions